ArticleFrontiers in neurology

Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study.

Fumiyuki Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.